Hosted on MSN12mon
Zantac maker settles 4,000 lawsuits linking discontinued heartburn drug to cancersSanofi, drugmaker behind Zantac, has agreed to settle 4,000 lawsuits The suits claim that discontinued Zantac contained cancer-causing chemicals READ MORE: Has heartburn pill that has been given ...
The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...
GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...
GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.
If you suffered losses exceeding $75,000 in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results